Quest Diagnostics (DGX)

NYSE Health Care Health Care Services S&P 500

$255.63

+0.89 (+0.35%)

Close of Nov 06, 2026 · end-of-day data

Source: Quest Diagnostics's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$7.21B	$7.40B	$7.53B	$7.73B	$9.44B	$10.79B	$9.88B	$9.25B	$9.87B	$11.04B
Cost of revenue	$4.62B	$4.72B	$4.93B	$5.04B	$5.80B	$6.58B	$6.45B	$6.20B	$6.63B	$7.37B
Gross profit	$2.90B	$2.68B	$2.60B	$2.69B	$3.63B	$4.21B	$3.43B	$3.05B	$3.24B	$3.67B
Selling, general & admin	$1.38B	$1.44B	$1.42B	$1.46B	$1.55B	$1.73B	$1.87B	$1.64B	$1.77B	$1.97B
Operating income	$1.28B	$1.17B	$1.10B	$1.23B	$1.97B	$2.38B	$1.43B	$1.26B	$1.35B	$1.56B
Interest expense	$144.00M	$153.00M	$169.00M	$180.00M	$166.00M	$152.00M	$148.00M	$163.00M	—	—
Pre-tax income	$1.09B	$1.03B	$926.00M	$1.08B	$1.88B	$2.60B	$1.24B	$1.13B	$1.18B	$1.32B
Income tax	$429.00M	$241.00M	$182.00M	$247.00M	$460.00M	$597.00M	$264.00M	$248.00M	$273.00M	$314.00M
Net income	$645.00M	$772.00M	$736.00M	$858.00M	$1.43B	$2.00B	$946.00M	$854.00M	$871.00M	$992.00M
EBITDA	$1.53B	$1.44B	$1.41B	$1.56B	$2.33B	$2.79B	$1.86B	$1.70B	$1.84B	$2.13B
EPS (basic)	$4.58	$5.63	$5.39	$6.36	$10.62	$15.85	$8.10	$7.59	$7.78	$8.87
EPS (diluted)	$4.51	$5.50	$5.29	$6.28	$10.47	$15.55	$7.97	$7.49	$7.69	$8.75
Diluted shares	142.00M	140.00M	139.00M	136.00M	136.00M	128.00M	118.00M	113.00M	113.00M	113.00M
Gross margin	40.2%	36.2%	34.6%	34.8%	38.5%	39.0%	34.7%	33.0%	32.9%	33.2%
Operating margin	17.7%	15.7%	14.6%	15.9%	20.9%	22.1%	14.4%	13.6%	13.6%	14.1%
Net margin	8.9%	10.4%	9.8%	11.1%	15.2%	18.5%	9.6%	9.2%	8.8%	9.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$359.00M	$137.00M	$135.00M	$1.19B	$1.16B	$872.00M	$315.00M	$686.00M	$549.00M	$420.00M
Receivables	$926.00M	$924.00M	$1.01B	$1.06B	$1.52B	$1.44B	$1.20B	$1.21B	$1.30B	$1.41B
Inventory	$82.00M	$95.00M	$99.00M	$123.00M	$223.00M	$208.00M	$192.00M	$190.00M	$188.00M	$189.00M
Total current assets	$1.53B	$1.31B	$1.39B	$2.49B	$3.06B	$2.74B	$1.90B	$2.37B	$2.39B	$2.38B
Goodwill	$6.00B	$6.33B	$6.56B	$6.62B	$6.87B	$7.09B	$7.22B	$7.73B	$8.86B	$8.95B
Total assets	$10.10B	$10.50B	$11.00B	$12.84B	$14.03B	$13.61B	$12.84B	$14.02B	$16.15B	$16.23B
Total current liabilities	$981.00M	$1.06B	$1.49B	$1.99B	$1.78B	$1.75B	$1.55B	$1.81B	$2.17B	$2.28B
Short-term debt	$6.00M	$36.00M	$464.00M	$804.00M	$2.00M	$2.00M	$2.00M	$303.00M	$602.00M	$504.00M
Long-term debt	$3.73B	$3.75B	$3.43B	$3.97B	$4.01B	$4.01B	$3.98B	$4.41B	$5.62B	$5.17B
Total debt	$3.73B	$3.78B	$3.89B	$4.77B	$4.01B	$4.01B	$3.98B	$4.71B	$6.22B	$5.67B
Total liabilities	$5.47B	$5.58B	$5.79B	$7.20B	$7.27B	$7.17B	$6.94B	$7.71B	$9.38B	$9.05B
Shareholders' equity	$4.63B	$4.92B	$5.22B	$5.64B	$6.76B	$6.44B	$5.89B	$6.31B	$6.78B	$7.17B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$1.12B	$1.18B	$1.20B	$1.24B	$2.00B	$2.23B	$1.72B	$1.27B	$1.33B	$1.89B
Capital expenditures	$293.00M	$252.00M	$383.00M	$400.00M	$418.00M	$403.00M	$404.00M	$408.00M	$425.00M	$527.00M
Free cash flow	$823.00M	$923.00M	$817.00M	$843.00M	$1.59B	$1.83B	$1.31B	$864.00M	$909.00M	$1.36B
Investing cash flow	-$127.00M	-$830.00M	-$801.00M	-$411.00M	-$772.00M	$21.00M	-$543.00M	-$1.06B	-$2.55B	-$631.00M
Financing cash flow	-$738.00M	-$592.00M	-$401.00M	$225.00M	-$1.27B	-$2.54B	-$1.73B	$160.00M	$1.08B	-$1.39B
Dividends paid	$223.00M	$247.00M	$266.00M	$286.00M	$297.00M	$309.00M	$305.00M	$314.00M	$331.00M	$353.00M
Share buybacks	$590.00M	$465.00M	$322.00M	$353.00M	$325.00M	$2.20B	$1.41B	$275.00M	$151.00M	$450.00M
Stock-based compensation	$69.00M	$79.00M	$61.00M	$56.00M	$97.00M	$79.00M	$77.00M	$77.00M	$88.00M	$88.00M
Depreciation & amortization	$249.00M	$270.00M	$309.00M	$329.00M	$361.00M	$408.00M	$437.00M	$439.00M	$493.00M	$570.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$2.29B	$2.37B	$2.40B	$2.49B	$2.62B	$2.65B	$2.76B	$2.82B	$2.81B	$2.90B	$3.04B	$3.10B
Cost of revenue	$1.55B	$1.59B	$1.59B	$1.68B	$1.76B	$1.79B	$1.82B	$1.87B	$1.90B	$1.95B	$2.02B	$2.06B
Gross profit	$736.00M	$771.00M	$804.00M	$811.00M	$858.00M	$863.00M	$943.00M	$949.00M	$910.00M	$942.00M	$1.03B	$1.04B
Selling, general & admin	$407.00M	$440.00M	$416.00M	$448.00M	$466.00M	$476.00M	$486.00M	$501.00M	$504.00M	$504.00M	$529.00M	$523.00M
Operating income	$267.00M	$300.00M	$355.00M	$330.00M	$361.00M	$346.00M	$438.00M	$386.00M	$386.00M	$399.00M	$459.00M	$479.00M
Interest expense	$46.00M	$49.00M	$47.00M	—	—	—	—	—	—	—	—	—
Pre-tax income	$237.00M	$266.00M	$314.00M	$296.00M	$299.00M	$276.00M	$384.00M	$328.00M	$330.00M	$334.00M	$412.00M	$416.00M
Income tax	$40.00M	$66.00M	$74.00M	$65.00M	$68.00M	$59.00M	$97.00M	$77.00M	$81.00M	$74.00M	$88.00M	$99.00M
Net income	$192.00M	$194.00M	$229.00M	$226.00M	$222.00M	$220.00M	$282.00M	$245.00M	$245.00M	$252.00M	$320.00M	$312.00M
EBITDA	$376.00M	$416.00M	$472.00M	$455.00M	$496.00M	$486.00M	$581.00M	$528.00M	$531.00M	$546.00M	$605.00M	$626.00M
EPS (basic)	$1.72	$1.74	$2.05	$2.01	$1.98	$1.97	$2.51	$2.18	$2.21	$2.27	$2.88	$2.82
EPS (diluted)	$1.70	$1.72	$2.03	$1.99	$1.95	$1.94	$2.47	$2.16	$2.18	$2.24	$2.84	$2.78
Diluted shares	-1.00M	112.00M	112.00M	113.00M	1.00M	113.00M	113.00M	113.00M	0	112.00M	112.00M	112.00M
Gross margin	32.2%	32.6%	33.5%	32.6%	32.7%	32.5%	34.2%	33.7%	32.4%	32.5%	33.7%	33.6%
Operating margin	11.7%	12.7%	14.8%	13.3%	13.8%	13.0%	15.9%	13.7%	13.8%	13.8%	15.1%	15.5%
Net margin	8.4%	8.2%	9.6%	9.1%	8.5%	8.3%	10.2%	8.7%	8.7%	8.7%	10.5%	10.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$686.00M	$474.00M	$271.00M	$764.00M	$549.00M	$188.00M	$319.00M	$432.00M	$420.00M	$393.00M	$626.00M	$797.00M
Receivables	$1.21B	$1.32B	$1.32B	$1.38B	$1.30B	$1.40B	$1.42B	$1.46B	$1.41B	$1.59B	$1.67B	$1.71B
Inventory	$190.00M	$181.00M	$182.00M	$184.00M	$188.00M	$189.00M	$187.00M	$186.00M	$189.00M	$225.00M	$233.00M	$218.00M
Total current assets	$2.37B	$2.23B	$2.02B	$2.62B	$2.39B	$2.08B	$2.20B	$2.41B	$2.38B	$2.57B	$2.84B	$3.12B
Goodwill	$7.73B	$7.83B	$7.88B	$8.61B	$8.86B	$8.85B	$8.88B	$8.90B	$8.95B	$9.12B	$9.11B	$9.11B
Total assets	$14.02B	$13.95B	$13.88B	$16.09B	$16.15B	$15.80B	$15.97B	$16.20B	$16.23B	$16.67B	$16.94B	$17.22B
Total current liabilities	$1.81B	$2.30B	$2.01B	$2.09B	$2.17B	$1.44B	$2.02B	$2.13B	$2.28B	$2.18B	$1.79B	$1.83B
Short-term debt	$303.00M	$906.00M	$606.00M	$603.00M	$602.00M	$1.00M	$504.00M	$504.00M	$504.00M	$503.00M	$10.00M	$10.00M
Long-term debt	$4.41B	$3.80B	$3.82B	$5.65B	$5.62B	$5.86B	$5.17B	$5.17B	$5.17B	$5.16B	$5.63B	$5.54B
Total debt	$4.71B	$4.71B	$4.42B	$6.25B	$6.22B	$5.86B	$5.67B	$5.67B	$5.67B	$5.66B	$5.64B	$5.55B
Total liabilities	$7.71B	$7.52B	$7.26B	$9.29B	$9.38B	$8.87B	$8.74B	$8.94B	$9.05B	$9.31B	$9.42B	$9.59B
Shareholders' equity	$6.31B	$6.43B	$6.62B	$6.81B	$6.78B	$6.93B	$7.23B	$7.26B	$7.17B	$7.37B	$7.52B	$7.63B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$527.00M	$154.00M	$360.00M	$356.00M	$464.00M	$314.00M	$544.00M	$563.00M	$465.00M	$278.00M	$597.00M	$611.00M
Capital expenditures	$72.00M	$104.00M	$92.00M	$106.00M	$123.00M	$117.00M	$108.00M	$144.00M	$158.00M	$114.00M	$138.00M	$166.00M
Free cash flow	$455.00M	$50.00M	$268.00M	$250.00M	$341.00M	$197.00M	$436.00M	$419.00M	$307.00M	$164.00M	$459.00M	$445.00M
Investing cash flow	-$114.00M	-$213.00M	-$200.00M	-$1.63B	-$502.00M	-$115.00M	-$124.00M	-$201.00M	-$191.00M	-$152.00M	-$134.00M	-$169.00M
Financing cash flow	$130.00M	-$153.00M	-$363.00M	$1.77B	-$170.00M	-$561.00M	-$293.00M	-$247.00M	-$287.00M	-$152.00M	-$229.00M	-$271.00M
Dividends paid	$80.00M	$79.00M	$84.00M	$84.00M	$84.00M	$84.00M	$90.00M	$89.00M	$90.00M	$88.00M	$96.00M	$95.00M
Share buybacks	$275.00M	—	—	—	$151.00M	—	—	$150.00M	$300.00M	—	—	$150.00M
Stock-based compensation	$19.00M	$22.00M	$20.00M	$19.00M	$27.00M	$22.00M	$21.00M	$20.00M	$25.00M	$20.00M	$23.00M	$20.00M
Depreciation & amortization	$109.00M	$116.00M	$117.00M	$125.00M	$135.00M	$140.00M	$143.00M	$142.00M	$145.00M	$147.00M	$146.00M	$147.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.